Best Online HRT Providers for Women Over 50 (2026)
By The HRT Index Editorial Team · Published 2026-05-15 · Last reviewed by editors: 2026-05-26
Editorial research — not medically reviewed by a clinician.
No active affiliate links on this page as of 2026-05-26.
By The HRT Index Editorial Team
Published · Last verified:
Editorial research — not medically reviewed by a clinician. Why this label →
The Short Answer First
The best online HRT providers for women over 50 are Midi Health (best for women with commercial PPO insurance), Alloy (best transparent cash-pay path), Stella (best insurance plus coaching), and Elektra Health(the standout if you need Medicare or Medicaid billing). Five more providers — Evernow, Gennev, Pandia Health, Wisp, Winona, and Hers — fit specific situations we’ll show you below.
First: starting HRT after 50 is not automatically too late. The key line is whether you are under 60 or within 10 years of your final period, and whether your medical history makes systemic hormone therapy appropriate (The Menopause Society, 2022).
Second: not every provider is built for women over 50. Some are great for 40-year-olds in early perimenopause and weaker for the post-menopausal patient. We scored all nine providers in our Over-50 Fit Matrix against six criteria that matter more after 50.
If this is you, start here
| If this describes you | Start with | Why |
|---|---|---|
| I have PPO insurance | Midi Health | Bills most major commercial PPO plans for the visit |
| I need Medicare or Medicaid coverage | Elektra Health | States it is the first virtual menopause provider to accept Medicare and Medicaid |
| I have insurance and want coaching support | Stella | In-network with many plans; screens 65 risk factors; adds lifestyle coaching |
| I want a scheduled doctor visit + dietitian | Gennev | 30-minute video visits; doctor and registered dietitian model |
| I’m paying cash, want prices upfront | Alloy | Published product pricing; estradiol patch from $74.99/mo |
| I want ongoing messaging instead of visits | Evernow | Membership from $35/mo (verify current pricing at checkout) |
| My main issue is vaginal dryness or painful sex | Wisp | Estradiol vaginal cream starting at $20 |
| I want reliable monthly medication delivery | Pandia Health | Annual membership from $34.99/mo (medication separate) |
| I specifically want compounded “bioidentical” options | Winona | Large mixed FDA-approved and compounded formulary |
| I want a simple, familiar consumer-app experience | Hers | Bundled menopause plans from $79/mo on annual plan |
What we actually verified
We pulled the data on this page from each provider’s public pricing pages, FAQs, support documentation, and clinical policy pages between May 20 and May 27, 2026. We cross-checked medical and regulatory claims against the FDA, the Menopause Society, ACOG, AUA, ASHP, and DEA primary sources. We did not interview every patient quoted; testimonials are sourced and linked. Anything we couldn’t fully verify is flagged so you can spot-check before acting.
What Are the Best Online HRT Providers for Women Over 50?
The best online HRT providers for women over 50 are Midi Health (best overall for insured women), Elektra Health (best for Medicare or Medicaid coverage), Alloy (best transparent cash-pay path), Stella (best insurance plus coaching), Evernow (best flexible membership), Gennev (best higher-touch doctor and dietitian model), Pandia Health (best low-cost continuity), Wisp (best for vaginal-first symptoms), Winona (best for compounded-focused options, with caveats), and Hers (best simple consumer-brand option).
We evaluated nine telehealth providers that women over 50 can access in the United States in 2026, plus Elektra Health as a routing alternative for Medicare and Medicaid coverage. We graded each on six things that matter more after 50 than before: insurance and Medicare friendliness, menopause-trained clinicians, FDA-approved-first medications, vaginal estrogen access, long-term care continuity, and whether intake forms understand the 10-year window after menopause.
Is 50 Too Late to Start HRT? The 10-Year Window, Explained.
Starting HRT after 50 is not automatically too late. For healthy women with bothersome menopause symptoms, starting systemic hormone therapy before age 60 or within 10 years of menopause is generally considered to have a more favorable benefit-risk profile, but the decision still depends on your medical history (The Menopause Society, 2022).
Here’s the rule most menopause clinicians are using now. If you start HRT before age 60 — or within 10 years of your last period — and you have bothersome symptoms, the benefits typically outweigh the risks for most healthy women. This is sometimes called the “window of opportunity.”
Ages 50–55 (you’re well inside the window)
You’re in the sweet spot. Most women in this age range without major contraindications are good candidates for systemic HRT. Any of the providers below can be a reasonable starting point. Pick by insurance and care preference, not by age.
Ages 55–60 (still usually inside the window)
You’re typically still inside the 10-year window unless you went through menopause unusually early. Most providers below remain appropriate. We’d lean slightly toward the menopause-specialty clinics (Midi, Stella, Alloy, Gennev) over the consumer-brand options at this age — the conversation deserves a clinician who does this every day.
Ages 60–65 (it depends)
You may still be inside the window if your last period was within the last 10 years. You may not be if menopause hit you earlier. This is the age where an honest conversation matters — not just a quiz, not just a checkout. We recommend starting with Midi or Gennev specifically, or finding a Menopause Society Certified Practitioner near you.
Ages 65+ (different conversation entirely)
Starting systemic HRT for the first time at 65 or older is not impossible, but it’s not the right decision to make through an online clinic alone. Vaginal estrogen for vaginal dryness or recurrent UTIs is often still appropriate at any age and has minimal systemic absorption — Wisp or your local pharmacy may both be reasonable for that specifically.
What Changed in November 2025 — and What It Means for Women Over 50
On , the FDA announced it was initiating removal of broad boxed-warning language about cardiovascular disease, breast cancer, and probable dementia from estrogen-containing menopausal hormone therapy products. In February 2026, the FDA approved labeling changes for the first six products. This was the biggest regulatory shift in menopause care in over two decades.
| Date | What happened | Source |
|---|---|---|
| 1991 | Women’s Health Initiative (WHI) launched | NIH/WHI |
| July 2002 | WHI early results released; HRT prescribing fell sharply | WHI initial paper |
| 2017 | Menopause Society revises position statement: HRT favorable for women under 60 or within 10 years of menopause onset | The Menopause Society |
| Stroke journal study of nearly 57,000 postmenopausal women with prior ischemic stroke found no increased recurrent-stroke risk with vaginal estrogen tablets | American Heart Association | |
| Menopause Society annual meeting analysis examined timing of estrogen therapy and rates of breast cancer, heart attack, and stroke | The Menopause Society | |
| FDA and HHS announce initiation of removal of boxed warnings on estrogen-containing HRT | FDA press release | |
| FDA approves labeling changes for first 6 HRT products | FDA labeling-change announcement | |
| Ongoing 2026 | 29 drug companies submitting label changes; rollout continues | FDA |
What the change actually means
Three things. First, the FDA is bringing its regulatory communication closer to what menopause specialists have known for over a decade. Second, the change does not mean HRT is risk-free. The risk language did not vanish from labeling: cardiovascular disease and breast-cancer risks remain in Warnings and Precautions, and the endometrial-cancer boxed warning remains for systemic estrogen-alone products. Third, the labeling change has no effect on compounded products — those were already unreviewed.
What this means for you:If a doctor scared you off HRT 10 or 15 years ago, you weren’t wrong to be cautious. The science evolved. Your specific risk depends on your age at starting, the route of medication (patch vs. pill), your dose, how long you stay on it, whether you have a uterus, and your personal medical history. The conversation today is different than the conversation in 2003.
The Over-50 HRT Fit Score — Our Methodology
Our Over-50 HRT Fit Score grades each provider 0–5 on six criteria that matter more after 50: insurance and Medicare access, menopause-trained clinicians (especially MSCP-credentialed), FDA-approved medications as the default, vaginal estrogen access, care continuity, and 10-year-window awareness in intake. Total possible: 30. Midi leads at 27; Alloy and Stella tie at 25.
| Criterion | Why it matters more after 50 |
|---|---|
| Insurance / Medicare friendliness | A larger share of women 50+ are insured or approaching Medicare. Cost reality is different. |
| MSCP-credentialed clinicians | MSCP = Menopause Society Certified Practitioner. After 50, the conversation gets more complex — bone health, vaginal symptoms, cardiovascular timing. A specialist helps. |
| FDA-approved-first formulary | Older patients tend to have more medications and more medical history. FDA-approved products carry the documented safety record. Compounded products do not. |
| Vaginal estrogen access | An estimated 45–77% of postmenopausal women have genitourinary syndrome of menopause. It’s the most under-treated symptom in this age group. |
| Care continuity | HRT after 50 is often multi-year therapy. One-and-done prescribing is a worse fit than for short-term symptom relief. |
| 10-year-window awareness in intake | If a provider’s intake doesn’t ask when your last period was, it can’t apply the most important clinical concept for the 50+ patient. |
The full scoring table
| Provider | Insurance / Medicare | MSCP clinicians | FDA-approved default | Vaginal estrogen | Continuity | Window-aware intake | Total /30 |
|---|---|---|---|---|---|---|---|
| Midi Health | 4 | 5 | 5 | 5 | 4 | 4 | 27/30 |
| Alloy | 2 | 5 | 5 | 4 | 5 | 4 | 25/30 |
| Stella | 4 | 4 | 5 | 4 | 4 | 4 | 25/30 |
| Evernow | 3 | 4 | 5 | 3 | 4 | 5 | 24/30 |
| Gennev | 3 | 4 | 5 | 4 | 4 | 3 | 23/30 |
| Pandia Health | 3 | 3 | 5 | 4 | 5 | 3 | 23/30 |
| Wisp | 2 | 2 | 5 | 5 | 2 | 2 | 18/30 |
| Winona | 2 | 3 | 2 | 4 | 3 | 3 | 17/30 |
| Hers | 2 | 2 | 5 | 3 | 3 | 2 | 17/30 |
Scores reflect public materials verified May 20–27, 2026. Elektra Health is the standout option for Medicare and Medicaid coverage and is covered separately in the insurance section below.
See Your Top 2 Matches by Over-50 Fit Score (60-Second Quiz) →Which Online HRT Providers Take Insurance, Medicare, or Medicaid?
Most online HRT providers do not bill Medicare or Medicaid. Midi bills most major commercial PPO plans but does not bill Medicare and does not treat Medicaid/Medi-Cal patients. Stella, Gennev, and Evernow have insurance-related models for commercial plans.Elektra Health states it is the first virtual menopause provider to accept Medicare and Medicaid. Alloy, Winona, Hers, Wisp, and Pandia are primarily cash-pay (HSA/FSA usually accepted).
| Provider | Commercial insurance | Medicare | Medicaid |
|---|---|---|---|
| Midi Health | Bills major PPO plans | Self-pay only; does not bill Medicare | Not accepted |
| Elektra Health | Yes (per Elektra) | Yes (per Elektra) | Yes (per Elektra) |
| Stella | In-network with many plans | Verify your specific plan | Verify your specific plan |
| Gennev | Yes (plan-dependent) | Verify your specific plan | Verify your specific plan |
| Evernow | Video visits may be covered | Not accepted for video visits | Not accepted for video visits |
| Alloy | Cash-pay (HSA/FSA) | Cash-pay | Cash-pay |
| Pandia Health | Membership cash; meds may use insurance | Verify | Verify |
| Winona | Cash-pay (HSA/FSA) | Cash-pay | Cash-pay |
| Wisp | Cash-pay (HSA/FSA) | Cash-pay | Cash-pay |
| Hers | Cash-pay | Cash-pay | Cash-pay |
If Medicare or Medicaid is your deciding factor
Elektra Healthis the option to compare first — it states it is the first virtual menopause provider to accept Medicare and Medicaid, with wide commercial coverage in addition. Verify your specific plan and state coverage directly with Elektra before signing up.
If Elektra is unavailable in your state, the realistic alternatives are:
- An in-person Menopause Society Certified Practitioner via the menopause.org directory
- An in-network OB/GYN through your plan’s directory who is willing to manage menopause care
- Self-pay at one of the cash-pay clinics above (with Part D or commercial drug coverage handling the medication at your pharmacy)
The 9 Providers, Reviewed for Women Over 50
Each review opens with the verdict, the Over-50 Fit Score, what we like, the trade-offs, and who it fits. Provider links are non-affiliate editorial links as of May 27, 2026.
1. Midi Health — Best Overall for Insured Women Over 50
The clinical model is built around clinicians with menopause-specific training. Several of Midi’s clinicians hold the MSCP credential. Midi primarily emphasizes FDA-approved bioidentical options — estradiol patches, oral estradiol, vaginal estradiol — with oral or vaginal micronized progesterone for women with a uterus. Midi also currently lists some compounded out-of-pocket options for shortage situations, so ask which product you are actually being prescribed. Testosterone is discussed only in defined situations, only in listed states, and may require labs and more than one visit.
What we like
- Bills most major commercial insurance plans for the visit (rare in this category)
- All 50 states
- MSCP-credentialed clinicians on staff
- Broad FDA-approved formulary including vaginal estradiol
- Ongoing messaging between visits
If Medicare or Medicaid is your only coverage: Compare Elektra Health — it states it is the first virtual menopause provider to accept Medicare and Medicaid. If Elektra doesn’t fit your state or plan, use the Menopause Society’s MSCP directory to find an in-person menopause specialist.
2. Alloy — Best Transparent Cash-Pay Path
The clinical leadership is strong. Alloy’s medical advisory team includes menopause-specialty physicians, and the platform states that prescribing physicians hold the MSCP credential from the Menopause Society. Their default formulary is FDA-approved bioidentical hormones. They don’t prescribe compounded preparations as a routine offering, and they don’t currently prescribe testosterone for women.
What we like
- Published, predictable cash-pay pricing
- MSCP-credentialed prescribing physicians
- FDA-approved formulary as the default
- Fast intake — care plan can land within 12 business hours
- Free shipping; all 50 states
- Adjacent prescriptions (sleep, libido, hair, skin) under one care team
Trade-offs
- Does not bill insurance directly (HSA/FSA accepted; out-of-network reimbursement is possible)
- 3-month upfront billing and cancellation timing can create friction
- Alloy does not order or facilitate lab tests
3. Stella — Best Insurance + Coaching Support
What we like
- In-network with many commercial plans
- Self-pay pricing is reasonable for what’s included
- All 50 states
- Screens 65 risk factors at intake
- Coaching layer adds support beyond the prescription
- Designed specifically for the 35–70 age range
Trade-offs
- Smaller brand footprint than Midi, Alloy, or Evernow
- Does not currently prescribe testosterone
- Specific insurance and medication costs vary by plan (verify yours before signing up)
4. Evernow — Best Flexible Membership
The clinical model is asynchronous — most communication happens via secure messaging rather than scheduled video visits. What we like about Evernow specifically for the 50+ patient is that their intake clearly distinguishes perimenopause from postmenopause, and their formulary includes both cyclic and continuous micronized progesterone protocols. For a 50–55-year-old who is still cycling occasionally, that matters.
What we like
- Most flexible cost structure of any provider here
- All 50 states + DC
- Video visit option may be covered by major commercial insurance
- Intake explicitly handles late-perimenopause patients (still cycling)
- Membership includes both cyclic and continuous progesterone options
- Non-hormonal options (paroxetine, gabapentin) available if you can’t take HRT
Trade-offs
- Membership itself is cash-pay
- Asynchronous messaging is the default — scheduled video visits require the pay-per-visit option
- Does not accept Medicare or Medicaid
5. Gennev — Best Higher-Touch Doctor and Dietitian Model
Self-pay is $250 for the initial doctor visit and $199 for follow-ups. The RDN initial is $199; RDN follow-ups are $119. Gennev accepts insurance, though specific copays depend on your plan. They operate in all 50 states. They prescribe FDA-approved hormonal and non-hormonal options and send prescriptions to your pharmacy.
What we like
- Scheduled video visits with menopause-trained doctors
- Optional RDN add-on for nutrition and lifestyle planning
- All 50 states / all zip codes
- Insurance accepted
Trade-offs
- Cash-pay visit prices run higher than membership models
- Less name recognition than Midi or Alloy
6. Pandia Health — Best Low-Cost Continuity Option
What we like
- Lowest annual membership price among our nine main providers
- Auto-shipment reduces risk of running out mid-treatment
- Explicit attention to under-served patient populations
- FDA-approved formulary as the default
Trade-offs
- State and consultation availability should be verified before choosing
- Medication cost varies by your insurance and pharmacy
- Less menopause-specialty marketing than Midi or Alloy
7. Wisp — Best for Vaginal-First Symptoms
For a 50+ woman whose worst symptom is genitourinary (the bladder and vagina) rather than vasomotor (hot flashes), starting here is reasonable. Low-dose vaginal estrogen is minimally systemically absorbed compared with systemic HRT, which means it can sometimes be appropriate even for women who can’t or don’t want systemic HRT.
What we like
- Lowest-cost route to a legitimate vaginal estrogen prescription
- Narrow scope means fast, focused intake
- Now offers a menopause consult for systemic care
- No labs required for standard prescribing
- HSA/FSA accepted
Trade-offs
- Not a full menopause-specialty platform if your symptoms are systemic
- Less depth of ongoing clinician relationship
8. Winona — Best for Women Who Specifically Want Compounded Options
The part Winona’s marketing tends to gloss over: the active ingredients in compounded preparations may be FDA-approved, but the final compounded medication is not FDA-approved.The FDA states it does not have evidence that compounded “bioidentical” hormones are safer or more effective than FDA-approved hormone therapy. ACOG specifically advises against routine prescribing of compounded bioidentical menopausal hormone therapy when FDA-approved options exist. For most women over 50 who haven’t specifically chosen a compounded path, the FDA-approved-first providers (Midi, Alloy, Stella, Evernow, Gennev) are a more conservative starting point.
Pricing: estrogen body cream with progesterone from $89/month, FDA-approved patches from $149/month, oral tablets from $54/month, oral progesterone capsules from $39/month.
What we like
- Large mixed FDA-approved and compounded formulary
- No video call required if you prefer asynchronous intake
- HSA/FSA accepted
Trade-offs
- Mix of FDA-approved and compounded products — ask which you’re being prescribed
- No direct insurance billing
- Doesn’t prescribe testosterone for women
- Verify state availability in the intake flow before signing up
9. Hers — Best Simple Consumer-Brand Cash-Pay Option
Hers uses licensed providers trained in women’s health; it is not positioned as a menopause-specialty physician clinic in the same way as Midi, Gennev, Stella, or Elektra. For a 50+ woman with no complications who has already decided exactly what she wants, that may be fine. For a complex case, it may not be.
What we like
- Most familiar consumer-brand experience in the category
- Fast intake to first prescription
- Predictable bundled pricing
- FDA-approved formulary
Trade-offs
- Not available in all 50 states (verify yours before signing up)
- Annual-plan structure can create commitment friction
- Less menopause-specialty depth than the top five
How to Choose by Your Specific Situation
The right provider changes once you factor in insurance, age, time since menopause, uterus status, symptoms, and medication preference. Match yourself to the situation below.
If you have PPO insurance
Start with Midi Health. Compare against Stella for the coaching layer or Gennev if you want a scheduled doctor visit. Verify your specific plan covers the menopause visit before you book — coverage details vary.
If you have HMO or limited insurance
Most online HRT providers are out-of-network for HMOs. Your realistic choices are: pay out-of-pocket at one of the cash-pay-friendly providers (Alloy, Evernow, Pandia); try Midi or Stella as a self-pay patient; or find an in-network OB/GYN through your plan and ask specifically for a menopause-trained provider.
If you have Medicare or Medicaid only
Most of the online HRT clinics on this list will not bill your plan. Midi cannot treat Medicaid/Medi-Cal patients and does not bill Medicare. Evernow does not accept Medicare or Medicaid for video visits. The exception is Elektra Health — it states it is the first virtual menopause provider to accept Medicare and Medicaid. Verify your specific plan and state directly with Elektra before signing up. If Elektra is not available in your state or plan, use the Menopause Society MSCP directory at menopause.org.
If you still have a uterus
Choose any of the top six, but make sure progesterone is part of your treatment plan if you’re prescribed systemic estrogen. The FDA kept the endometrial-cancer boxed warning specifically for unopposed systemic estrogen in women with a uterus. This isn’t optional — it’s the protective hormone that’s added for exactly this reason.
If you had a hysterectomy
You may not need progesterone. The estrogen-only path is often appropriate after a hysterectomy. But the conversation depends on what was removed and your full history. Don’t guess — let the prescribing clinician confirm.
If your main symptom is vaginal dryness, painful sex, or recurrent UTI
Start with Wisp for the lowest-cost path to vaginal estradiol cream. Or start with Alloy if you want both vaginal estrogen and the option of adding systemic HRT later under one provider. The American Urological Association recommends clinicians offer vaginal estrogen therapy to peri- and postmenopausal women with recurrent UTIs to reduce future UTIs.
If you’re more than 10 years past menopause or you’re 60+
This is the situation where an online checkout is the wrong starting point for systemic HRT. The conversation needs a clinician who can see your full history, not a questionnaire. Three reasonable paths: Midi or Gennev specifically, because their clinical model can handle the conversation; an in-person Menopause Society Certified Practitioner via menopause.org; or for vaginal-only symptoms, vaginal estrogen (Wisp or your local pharmacy) may still be appropriate at any age.
If you want compounded “bioidentical” hormones specifically
If you’ve researched compounded bioidentical hormone therapy, discussed it with your doctor, and decided you want that path: Winona has the deepest formulary. If you haven’t done that research yet, start with the FDA-approved-first providers (Midi, Alloy, Stella). The distinction matters more than most marketing materials make clear.
How Much Does Online HRT Really Cost After 50?
Insurance-billed visits at Midi typically run a $30–$50 specialty copay. Cash-pay membership and clinic models range from $35/month (Evernow annual) to $250 per visit (Midi or Gennev self-pay). Medication is billed separately — FDA-approved generic estradiol and progesterone often cost $10–$30/month at retail pharmacy with commercial drug coverage or a coupon. The honest first-year cost for an insured patient is often $400–$800; for a cash-pay patient, $800–$2,000+ depending on provider and medication.
The 5 costs most pages hide
- The visit or membership fee — what you pay to talk to a clinician
- The medication cost — separate from the visit, billed at the pharmacy or shipped
- Labs or imaging — sometimes ordered, sometimes not
- Follow-up visits — typically required at 3–6 months and beyond
- Cancellation, refill, or shipping friction — fees and timing windows you might not see at signup
Three worked examples
Example 1: Insured 53-year-old at Midi Health
- First visit copay: ~$30 (varies by plan)
- Follow-up copay: ~$25 every 3–6 months
- Estradiol patch at retail pharmacy with commercial prescription coverage or coupon: ~$15–$30/month
- Oral progesterone at retail pharmacy: ~$10–$25/month
Estimated all-in monthly cost after first visit: $25–$55/month
Estimated first year: $400–$700
Example 2: Cash-pay 56-year-old at Alloy
- One-time consultation fee: $49
- Estradiol patch: $74.99/month
- Oral progesterone: $23/month
Estimated monthly cost: ~$98/month after first month
Estimated first year: $1,225
Example 3: Medicare beneficiary going local (Elektra Health)
- Self-pay or insurance-billed visit at Elektra Health (verify your plan and state directly)
- Estradiol patch with Part D coverage: typically $10–$30/month depending on plan formulary
- Oral progesterone with Part D coverage: typically $10–$25/month depending on plan
Estimated monthly cost after first visit: $20–$55/month depending on plan
Note: Medicare drug costs depend on Part D or Medicare Advantage formulary, tier, deductible, pharmacy, and dose.
What changes the math most
- Whether you use insurance for the visit (saves $200+ per visit)
- Whether your medication is FDA-approved (generics are inexpensive; compounded is not)
- Whether labs are ordered (covered by insurance most of the time; out-of-pocket otherwise)
- Whether you pay annually or monthly (annual plans save 20–40% at most providers)
What You’ll Actually Get — Estradiol Patches, Pills, Gels, and Vaginal Estrogen
Most online HRT providers can prescribe FDA-approved estradiol in patch, oral, gel, or spray form, plus oral or vaginal micronized progesterone, plus low-dose vaginal estradiol for genitourinary symptoms. As of April 2026, estradiol patches have been on intermittent shortage in the US, so flexibility on delivery method matters.
Estradiol patches (transdermal, applied to skin)
A common systemic option for women over 50. Estradiol delivered through the skin avoids the liver ‘first pass’ effect, which means it doesn’t raise clotting-factor production the way oral estradiol does. For some clot-risk considerations, clinicians often prefer transdermal estrogen over oral estrogen, but cardiovascular disease or prior clot/stroke history needs individualized clinician review before systemic hormone therapy.
Oral estradiol (pill)
A reasonable option for low-risk patients. Less expensive than the patch. Goes through the liver, which slightly raises clotting risk compared with transdermal. Often the cheapest delivery form when filled at a retail pharmacy with a discount card — generic estradiol pills can be under $15/month.
Estradiol gel or spray
A transdermal alternative if patches are unavailable or you don’t like adhesive on your skin. Alloy lists Evamist (estradiol spray) and estradiol gel options around $69.99/month. Risk profile similar to the patch.
Oral or vaginal micronized progesterone
The protective second hormone for women with a uterus on systemic estrogen. Most providers prescribe oral micronized progesterone (often dosed at bedtime, because it has a mild sedating effect that can help sleep). Vaginal progesterone is sometimes used for women who don’t tolerate the oral form.
Low-dose vaginal estradiol
A separate, very-low-systemic-exposure treatment for vaginal dryness, painful sex, and recurrent UTIs. Comes as cream, tablet, or ring. Often appropriate even for women who can’t take systemic HRT. This is the most under-treated symptom set in the 50+ age group.
Which online HRT provider is best for estradiol patches?
No single online provider has guaranteed patch supply because they all rely on the same pharmaceutical manufacturers. Providers that send prescriptions to your local pharmacy (Midi, Stella, Gennev, Evernow) may give you more flexibility to fill at whichever pharmacy has stock. Providers that ship from a single source (Alloy, Winona) may face fulfillment delays during shortages.
FDA-Approved Bioidentical vs. Compounded “Bioidentical” — the Distinction That Matters More After 50
“Bioidentical” refers to hormones that match the structure of what your body produces — 17-beta-estradiol and micronized progesterone are both bioidentical, and both are available in FDA-approved products.“Compounded bioidentical” refers to preparations mixed at a compounding pharmacy to a clinician’s order. They’re not the same.
The FDA states it does not have evidence that compounded bioidentical hormones are safer or more effective than FDA-approved hormone therapy. The conflation of these two categories drives more bad decisions in menopause care than almost any other piece of marketing language.
Bioidentical, in the chemical sense:A hormone molecule that’s identical to what your ovaries used to make. 17-beta-estradiol is bioidentical. So is micronized progesterone. Both have been available as FDA-approved products for decades — Estrace, Vivelle-Dot, Climara, Estring, Prometrium, and many generics.
Compounded bioidentical:A hormone preparation mixed by a compounding pharmacy, often as a cream or troche. The active ingredients may be FDA-approved, but the final compounded medication is not FDA-approved. Compounded preparations are not reviewed by the FDA for safety, effectiveness, or quality before they’re sold. ACOG issued a clinical consensus in November 2023 advising against routine prescribing of compounded bioidentical menopausal hormone therapy when FDA-approved options exist.
What this means for the over-50 patient:If you’ve heard “bioidentical is safer,” ask the next question: “Bioidentical and FDA-approved, or bioidentical and compounded?” Those are different products with different evidence bases. For most women over 50 who haven’t specifically chosen the compounded path, the FDA-approved-first providers on this list (Midi, Alloy, Stella, Evernow, Gennev, Pandia, Hers) are a more conservative starting point.
Vaginal Estrogen for Women Over 50 — When Local Is the Right First Step
Genitourinary syndrome of menopause (GSM) — vaginal dryness, painful sex, urinary urgency, and recurrent UTIs after menopause — is treatable with low-dose vaginal estradiol cream, tablets, or rings. GSM affects an estimated 45–77% of postmenopausal women, according to a systematic review cited by JAMA Network Open (December 2025). Low-dose vaginal estrogen is minimally systemically absorbed compared with systemic HRT.
It’s common
Nearly half to three-quarters of postmenopausal women have at least one symptom.
It gets worse without treatment
Unlike hot flashes, which often improve over time, GSM symptoms tend to progress.
It’s eminently treatable
Low-dose vaginal estradiol works well for most women.
It’s appropriate for many women who can’t take systemic HRT
Because vaginal estrogen is minimally systemically absorbed.
Provider options for vaginal estrogen specifically
| Provider | Vaginal estrogen offering | Best for |
|---|---|---|
| Wisp | Estradiol cream from $20; vaginal tablets | Lowest-cost path; vaginal-first symptoms |
| Alloy | Estradiol cream available | Women wanting both vaginal and systemic care under one provider |
| Midi Health | FDA-approved vaginal estradiol | Insured women wanting full menopause-specialty care |
| Gennev | FDA-approved vaginal estradiol | Women wanting a scheduled doctor visit |
| Your local pharmacy | Generic vaginal estradiol with any prescription | Medicare or Medicaid patients; lowest-cost retail path |
When Online HRT Is Not the Right Choice
Online HRT is not appropriate for every patient. The FDA lists situations where women should not take hormone therapy: pregnancy, unexplained vaginal bleeding, certain cancers (especially estrogen-sensitive breast cancer), history of stroke or heart attack, history of blood clots, and active liver disease. If any of these apply to you, online HRT is not your starting point — in-person evaluation is.
Do not start online HRT if you have:
- Personal history of breast cancer or other estrogen-sensitive cancer
- Unexplained vaginal bleeding (this needs evaluation before anything else)
- History of blood clots (deep vein thrombosis, pulmonary embolism)
- History of stroke or heart attack
- Active liver disease
- Uncontrolled high blood pressure
- Possible or active pregnancy
- Migraine with aura (often manageable with transdermal estrogen, but needs clinical review first)
If any of the contraindications above apply to you, the right next step is an in-person evaluation with a doctor who can review your full history. We’d rather you skip our quiz than start the wrong treatment.
For vaginal-only symptoms: Even with some of the contraindications above, low-dose vaginal estrogen may still be appropriate because systemic absorption is minimal. This is a conversation to have with your oncology team (if you have a cancer history) or your primary doctor, not an online clinic alone.
The 12 Questions to Ask Before Paying Any Online HRT Provider
Before paying for online HRT, you should know your provider’s answers to these 12 specific questions. Save this list. Open the provider’s intake page. Walk through these before you enter a credit card.
If a provider can’t or won’t answer any of these clearly, that’s information. Move on.
Get These Questions Personalized to Your Situation in 60 Seconds →What Real Women Over 50 Say
We’ve kept this section deliberately small. Below are real, sourced patient experiences from public provider pages. Individual experiences vary, results are not typical, and these are not medical efficacy claims — they’re care-experience evidence.
“Midi was so easy: I got a same-day appointment and they took my insurance.”
— Patient testimonial published on Midi Health’s pricing and insurance page
“I felt heard and seen.”
“My HRT specialist prescribed an estradiol patch .5 and the progesterone tablets as I requested. They allowed me to make that request and prescribed those when the time came.”
— Patient experience review of Alloy, published on Hormone Therapy Hub
These are individual care experiences and do not represent typical outcomes. Hormone therapy results vary by patient, symptom severity, dose, route, and time on treatment.
Frequently Asked Questions
What is the best online HRT provider for women over 50?
For most insured women over 50, Midi Health is the strongest starting point because it offers menopause-specialist virtual care, works in all 50 states, and bills most major PPO insurance plans. Stella is a strong insurance-friendly alternative with added coaching. Alloy is the strongest cash-pay path with published pricing. If you need Medicare or Medicaid billing, Elektra Health is the option to compare.
Is HRT safe after 50?
For most healthy women with bothersome menopause symptoms, starting hormone therapy within 10 years of menopause onset or before age 60 has a more favorable benefit-risk profile, according to current Menopause Society guidance. The FDA’s November 2025 labeling update initiated removal of boxed warnings about cardiovascular disease, breast cancer, and probable dementia from estrogen-containing HRT products; the risk language was not eliminated, but reframed. Individual risk depends on your medical history and should be reviewed with a clinician.
Can I start HRT after age 60 or more than 10 years past menopause?
It’s not automatically impossible, but it requires a real clinical conversation rather than an online checkout. The risk-benefit picture shifts after the 10-year window. We recommend an in-person Menopause Society Certified Practitioner or a higher-touch online provider (Midi or Gennev) for this situation rather than the consumer-app options.
Does Medicare or Medicaid cover online HRT?
Most online HRT clinics do not bill Medicare or Medicaid. Midi does not bill Medicare and cannot treat Medicaid/Medi-Cal patients. Evernow does not accept Medicare or Medicaid for video visits. Elektra Health is the exception — it states it is the first virtual menopause provider to accept Medicare and Medicaid. Verify your specific plan and state directly with Elektra. Many FDA-approved generic estradiol and progesterone prescriptions may be inexpensive under Part D or Medicare Advantage drug plans, depending on the plan formulary, tier, deductible, pharmacy, and dose.
What’s the difference between FDA-approved bioidentical and compounded bioidentical HRT?
‘Bioidentical’ means the hormone matches what your body produces. FDA-approved bioidentical products (like 17-beta-estradiol patches and micronized progesterone capsules) have been reviewed for safety and effectiveness. Compounded bioidentical preparations are mixed at compounding pharmacies and are not FDA-approved as finished products. The FDA states it does not have evidence that compounded bioidentical hormones are safer or more effective than FDA-approved hormone therapy. ACOG advises against routine compounded bioidentical prescribing when FDA-approved options exist.
Do I need bloodwork before starting HRT?
Not always. The Menopause Society notes that hormone levels during perimenopause fluctuate substantially, and a single blood draw is poorly diagnostic. Many providers prescribe based on symptoms, age, and medical history. Some order baseline labs (lipids, glucose, thyroid) to characterize overall risk. Whether you need labs is a clinical judgment call.
Do I need progesterone with estrogen after 50?
If you have a uterus and use systemic estrogen, yes — progesterone or a progestogen is added to protect against endometrial cancer. The FDA’s November 2025 labeling update kept the endometrial-cancer boxed warning for unopposed systemic estrogen specifically because this risk is real. If you’ve had a hysterectomy, estrogen-only may be appropriate.
Which online HRT provider has the best estradiol patch supply?
In 2026, estradiol transdermal patches have been on intermittent shortage according to ASHP. No single online provider has guaranteed supply because they all rely on the same pharmaceutical manufacturers. Providers that prescribe to your local pharmacy (Midi, Stella, Gennev, Evernow) may give you more flexibility to fill at whichever pharmacy has stock. Providers that ship from a single source (Alloy, Winona) may face fulfillment delays during shortages.
How long can I stay on HRT?
Current Menopause Society guidance has moved away from the older ‘shortest duration, lowest dose’ framing toward an individualized model. The decision to continue is reviewed periodically with your clinician based on ongoing symptoms, bone protection needs, evolving risk, and your preferences. There is no fixed external deadline.
Can I get testosterone through an online HRT provider?
Some providers prescribe low-dose testosterone for women, typically for distressing low sexual desire after estrogen therapy has been optimized. There is no FDA-approved testosterone product specifically for women in the United States — prescribing is off-label. Testosterone is also a Schedule III controlled substance regulated by the DEA, which means prescribing comes with additional requirements. It is not a first-line treatment for energy, mood, or weight.
What happens if my prescription is denied?
Some providers may decline to prescribe if your medical history shows a contraindication, if the symptom picture doesn’t fit, or if state licensing rules require an in-person visit first. A denial is not failure — it’s a clinician doing their job. If this happens, the right next step is usually an in-person menopause specialist via menopause.org.
How is The HRT Index funded?
The HRT Index is an independent comparison resource for HRT telehealth providers. As of May 27, 2026, we do not have active affiliate partnerships with the providers on this page. Provider links on this page are non-affiliate editorial links. If affiliate relationships are added later, affected links will be relabeled with sponsored disclosure. Rankings are determined by editorial judgment against our published methodology — not by commercial relationships.
Still Not Sure Which HRT Program Is Right for You?
You don’t need to memorize the differences between ten providers. Our free 60-second matching quiz asks about your age, time since your last period, symptoms, insurance, state, uterus status, medication preferences, and risk factors — then routes you to the right starting point with the questions to ask before you pay.
You’ll get your best-fit starting provider, a backup option, your estimated first 90-day cost, the 12 questions to ask before any provider charges you, and a clear “when to choose in-person care instead” note if that’s the right answer for your situation.
No email required to see the result.
Take Our Free 60-Second Matching Quiz →Sources
- FDA. HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy. .
- FDA. FDA Approves Labeling Changes to Menopausal Hormone Therapy Products. .
- FDA. Menopause Consumer Information. fda.gov.
- The Menopause Society. Hormone Therapy Position Statement. 2022.
- The Menopause Society. MSCP Certification. menopause.org.
- ACOG. Compounded Bioidentical Menopausal Hormone Therapy Clinical Consensus. .
- American Urological Association. Recurrent UTI Guideline. auanet.org.
- JAMA Network Open. Vaginal Estrogen Utilization Among Medicare Beneficiaries With Genitourinary Syndrome of Menopause. .
- Elektra Health. Does Insurance Cover Menopause Care? elektrahealth.com.
- ASHP. Estradiol Transdermal Drug Shortage page. .
- Reuters. Patients scramble to find estrogen patches as shortage worsens. .
- American Heart Association. Vaginal estrogen tablets may be safe for postmenopausal women who have had a stroke. .
- DEA. Schedule III Controlled Substances list.
- Provider public pricing and policy pages — joinmidi.com, myalloy.com, us.onstella.com, gennev.com, evernow.com, pandiahealth.com, bywinona.com, forhers.com/menopause, hellowisp.com, elektrahealth.com. Last verified .
About The HRT Index
The HRT Index is an independent comparison resource for HRT telehealth providers. We evaluate providers on transparent criteria, publish our methodology, source every factual claim, and update commercial details quarterly. This content is editorial research, not medical advice. Always consult a licensed clinician before starting, stopping, or changing hormone therapy.
More from The HRT Index